MARENGO
Live / Allowed — Publication / registration review complete (as of 25 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99449949
- Mark type
- Design + words
- Filed
- 17 Oct 2025
- Published for opposition
- 14 Apr 2026
- Attorney of record
- Alyssa M. Worsham
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in immunology and oncology; pharmaceutical preparations for use in treating cancer; pharmaceutical preparations for use in treating malignant tumors; pharmaceutical preparations for the treatment and prevention of cancer and immune system diseases and disorders; pharmaceutical preparations using antibodies to target malignant solid tumors and to promote protective tumor immunity; pharmaceutical preparations for triggering cytokine release for the expansion of an antigen-specific memory T cell repertoire for the purpose of treating cancer; pharmaceutical preparations for immune system activation and protection; pharmaceutical preparations for anti-cancer immune activation therapeutics; pharmaceuticals, namely, antibodies for the treatment of cancer; pharmaceutical preparations for use in the fields of immunology and oncology for treating cancer, infectious disease, auto-immune disease, and other diseases in connection with immune system dysfunction; vaccines; human vaccine preparations
Owner
- MARENGO THERAPEUTICS, INC., Cambridge, MA, US
Prosecution history
- 19 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Mar 2026 — NON-FINAL ACTION E-MAILED
- 12 Mar 2026 — NON-FINAL ACTION WRITTEN
- 05 Mar 2026 — ASSIGNED TO EXAMINER
- 04 Mar 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 04 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 17 Oct 2025 — NEW APPLICATION ENTERED